1. From the Office of Vaccines Research and Review, Food and Drug Administration, Rockville (K.C.), and the Global Virus Network (C.B.) and the Institute of Human Virology, University of Maryland School of Medicine (R.C.G.), Baltimore — all in Maryland; and the University of Pennsylvania and Vaxconsult — both in Philadelphia (S.P.).